Exact Mass: 291.17668
Exact Mass Matches: 291.17668
Found 127 metabolites which its exact mass value is equals to given mass value 291.17668,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Bunolol
C17H25NO3 (291.18343400000003)
C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D013565 - Sympatholytics D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists
Cyclopentolate
C17H25NO3 (291.18343400000003)
Cyclopentolate is only found in individuals that have used or taken this drug. It is a parasympatholytic anticholinergic used solely to obtain mydriasis or cycloplegia. [PubChem]By blocking muscarinic receptors, cyclopentolate produces dilatation of the pupil (mydriasis) and prevents the eye from accommodating for near vision (cycloplegia). S - Sensory organs > S01 - Ophthalmologicals > S01F - Mydriatics and cycloplegics > S01FA - Anticholinergics C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D010276 - Parasympatholytics D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018680 - Cholinergic Antagonists D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D009184 - Mydriatics C78283 - Agent Affecting Organs of Special Senses > C29706 - Mydriatic Agent
variotin
C17H25NO3 (291.18343400000003)
D - Dermatologicals > D01 - Antifungals for dermatological use > D01A - Antifungals for topical use > D01AA - Antibiotics C254 - Anti-Infective Agent > C514 - Antifungal Agent Same as: D01458
Levobunolol
C17H25NO3 (291.18343400000003)
Levobunolol is only found in individuals that have used or taken this drug. It is a nonselective beta-adrenoceptor antagonist used in the treatment of glaucoma. [PubChem]Levobunolols mechanism of action in reducing IOP is not clearly defined, but is believed to be due to a reduction of the production of aqueous humor via blockage of endogenous catecholamine-stimulated increases in cyclic adenosine monophosphate (AMP) concentrations within the ciliary processes. S - Sensory organs > S01 - Ophthalmologicals > S01E - Antiglaucoma preparations and miotics > S01ED - Beta blocking agents C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D013565 - Sympatholytics D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists C78283 - Agent Affecting Organs of Special Senses > C29705 - Anti-glaucoma Agent
Norcapsaicin
C17H25NO3 (291.18343400000003)
Isolated from the pungent principle of red pepper (Capsicum annuum). Norcapsaicin is found in many foods, some of which are herbs and spices, italian sweet red pepper, orange bell pepper, and red bell pepper. Norcapsaicin is found in herbs and spices. Norcapsaicin is isolated from the pungent principle of red pepper (Capsicum annuum
(3R)-3,5-dihydroxy-3-methylpentanoylcarnitine
(3R)-3,5-dihydroxy-3-methylpentanoylcarnitine is an acylcarnitine. More specifically, it is an (3R)-3,5-dihydroxy-3-methylpentanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. (3R)-3,5-dihydroxy-3-methylpentanoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine (3R)-3,5-dihydroxy-3-methylpentanoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].
Perlapine
4-(3,4-Dimethoxyphenyl)octahydro-2H-quinolizine-2-ol
C17H25NO3 (291.18343400000003)
(7aR)-8c-Aethyl-11c-methyl-(7ar,8ac,11ac,11bt,11cc)-dodecahydro-azepino[3,2,1-hi]furo[3,2-e]indol-2,10-dion|(7aR)-8c-ethyl-11c-methyl-(7ar,8ac,11ac,11bt,11cc)-dodecahydro-azepino[3,2,1-hi]furo[3,2-e]indole-2,10-dione|2-oxo-stenine|2-oxostenine|rel-(7aR,8R,8aS,11S,11aS,11bR,11cR)-8-ethyldodecahydro-11-methylazepino[3,2,1-hi]furo[3,2-e]indole-2,10-dione
C17H25NO3 (291.18343400000003)
(Benzoylamino)acetic acid octyl ester
C17H25NO3 (291.18343400000003)
(-)-sessilifoliamide C|(9R,9aS)-9-((1S)-1-((2R)-4-methyl-5-oxo-2,5-dihydrofuran-2-yl)propyl)octahydro-3H-pyrrolo[1,2-a]azepin-3-one|sessilifoliamide C
C17H25NO3 (291.18343400000003)
(5RS)-3-methyl-5-[(1SR,2SR,3aRS,10aSR,10bRS)-1-methyldecahydro-2H-furo[3,2-c]pyrrolo[1,2-a]azepin-2-yl]furan-2(5H)-one|neostemocochinine
C17H25NO3 (291.18343400000003)
eucatropine
C17H25NO3 (291.18343400000003)
C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent
C17H25NO3_Azepino[3,2,1-hi]furo[3,2-e]indole-2,10-dione, 8-ethyldodecahydro-11-methyl-, (7aR,8R,8aS,11S,11aS,11bR,11cR)
C17H25NO3 (291.18343400000003)
Norcapsaicin
C17H25NO3 (291.18343400000003)
tert-butyl 4-phenylmethoxypiperidine-1-carboxylate
C17H25NO3 (291.18343400000003)
3-ETHYL-1-((2-(TRIMETHYLSILYL)ETHOXY)METHYL)-1H-INDAZOL-6-AMINE
(2S,6S)-2,6-dibenzyl-2,3,5,6-tetrahydro-1H-imidazo[1,2-a]imidazole
tert-butyl 3-(2-hydroxyethyl)-3-phenylpyrrolidine-1-carboxylate
C17H25NO3 (291.18343400000003)
tert-butyl 4-benzyl-4-hydroxypiperidine-1-carboxylate
C17H25NO3 (291.18343400000003)
tert-butyl 4-(hydroxymethyl)-4-phenylpiperidine-1-carboxylate
C17H25NO3 (291.18343400000003)
4-[6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazin-2-yl]morpholine
tert-amyl 2-acetamido-2-deoxy-beta-d-glucopyranoside
1H-PYRROLO[2,3-B]PYRIDINE, 4-[4-(PHENYLMETHYL)-1-PIPERIDINYL]-
trans-4-[5-(4-ethylcyclohexyl)-2-pyrimidyl]benzonitrile
methyl (3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethyl-1-piperidinepropanoate
C17H25NO3 (291.18343400000003)
N-(4-FLUORO-2-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)BENZYL)CYCLOPROPANAMINE
2-(4-morpholino)pyrimidine-5-boronic acid pinacol ester
1-(3-fluoro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)pyrrolidine
3-Nitro-1-(4-octylphenyl)-1-propanone
C17H25NO3 (291.18343400000003)
TERT-BUTYL4-BENZYL-3-HYDROXYPIPERIDINE-1-CARBOXYLATE
C17H25NO3 (291.18343400000003)
3,4-Dimethoxy-alpha-pyrrolidinopentiophenone
C17H25NO3 (291.18343400000003)
Pecilocin
C17H25NO3 (291.18343400000003)
D - Dermatologicals > D01 - Antifungals for dermatological use > D01A - Antifungals for topical use > D01AA - Antibiotics C254 - Anti-Infective Agent > C514 - Antifungal Agent
7-Methyl-oct-6-enoic acid 4-hydroxy-3-methoxy-benzylamide
C17H25NO3 (291.18343400000003)
6-amino-2-[(5-amino-5-carboxypentan-2-yl)amino]-5-hydroxyhexanoic acid
1-[(E)-1-(4-Tert-butylphenyl)ethylideneamino]-3-propan-2-ylthiourea
1-(3,4-dimethoxyphenyl)-N-propan-2-yl-1-cyclopentanecarboxamide
C17H25NO3 (291.18343400000003)
2-Hydroxy-2-phenylacetic acid (1,2,6,6-tetramethyl-3-piperidinyl) ester
C17H25NO3 (291.18343400000003)
5-methyl-2-[(3S)-piperidin-3-yl]-3-pyridin-4-yl-1H-indole
cyclopentolate
C17H25NO3 (291.18343400000003)
S - Sensory organs > S01 - Ophthalmologicals > S01F - Mydriatics and cycloplegics > S01FA - Anticholinergics C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D010276 - Parasympatholytics D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018680 - Cholinergic Antagonists D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D009184 - Mydriatics C78283 - Agent Affecting Organs of Special Senses > C29706 - Mydriatic Agent
LEVOBUNOLOL
C17H25NO3 (291.18343400000003)
S - Sensory organs > S01 - Ophthalmologicals > S01E - Antiglaucoma preparations and miotics > S01ED - Beta blocking agents C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D013565 - Sympatholytics D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists C78283 - Agent Affecting Organs of Special Senses > C29705 - Anti-glaucoma Agent
methyl 8-hydroxy-14-methyl-3-azatetracyclo[9.3.1.0³,¹².0⁷,¹²]pentadec-10-ene-10-carboxylate
C17H25NO3 (291.18343400000003)
(2z,7as)-2-[(2e)-1-hydroxydec-2-en-1-ylidene]-tetrahydropyrrolizine-1,3-dione
C17H25NO3 (291.18343400000003)
(2r)-2-heptyl-2-hydroxy-6-methoxy-4-methyl-1h-indol-3-one
C17H25NO3 (291.18343400000003)
methyl (1s,7s,8r,12r,14s)-8-hydroxy-14-methyl-3-azatetracyclo[9.3.1.0³,¹².0⁷,¹²]pentadec-10-ene-10-carboxylate
C17H25NO3 (291.18343400000003)
(9r,9as)-9-[(1s)-1-[(2r)-4-methyl-5-oxo-2h-furan-2-yl]propyl]-octahydropyrrolo[1,2-a]azepin-3-one
C17H25NO3 (291.18343400000003)
annopodine
C17H25NO3 (291.18343400000003)
{"Ingredient_id": "HBIN016230","Ingredient_name": "annopodine","Alias": "NA","Ingredient_formula": "C17H25NO3","Ingredient_Smile": "CC1CC23C4CCCN2CC1CC3=C(CC4O)C(=O)OC","Ingredient_weight": "291.4 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "1323","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "12306652","DrugBank_id": "NA"}
6-methyl-1-(2-oxopyrrolidin-1-yl)dodeca-4,6-diene-1,8-dione
C17H25NO3 (291.18343400000003)
methyl (2s)-3-[(8r,9s,13s)-8-hydroxy-1-azatricyclo[7.3.1.0⁵,¹³]trideca-3,5-dien-13-yl]-2-methylpropanoate
C17H25NO3 (291.18343400000003)
(1s,4s,6r,9s,15r)-15-hydroxy-6-methyl-13-azatetracyclo[11.3.1.0¹,⁹.0⁴,⁹]heptadecane-2,8-dione
C17H25NO3 (291.18343400000003)
(1r,5s,6s,9s,15r,16s)-16-isopropyl-15-methyl-3,14-dioxa-11-azapentacyclo[7.5.1.1²,⁵.0¹,¹¹.0⁶,¹⁵]hexadecan-4-one
C17H25NO3 (291.18343400000003)
6-ethyl-2-hydroxy-6a,8,10-trimethyl-6h,7h,8h,9h,10h,10ah-isochromeno[4,3-c]pyridin-1-one
C17H25NO3 (291.18343400000003)
(1s,4s,5s,6s,9s)-5-hydroxy-6-methyl-13-azatetracyclo[11.3.1.0¹,⁹.0⁴,⁹]heptadecane-2,8-dione
C17H25NO3 (291.18343400000003)
methyl 8-hydroxy-14-methyl-3-azatetracyclo[9.3.1.0³,¹².0⁷,¹²]pentadec-11(15)-ene-10-carboxylate
C17H25NO3 (291.18343400000003)
(6r,6as,8s,10r,10as)-6-ethyl-2-hydroxy-6a,8,10-trimethyl-6h,7h,8h,9h,10h,10ah-isochromeno[4,3-c]pyridin-1-one
C17H25NO3 (291.18343400000003)
n,n-dimethyl-2-{1h,2h,3h,9h-pyrrolo[2,1-b]quinazolin-3-yl}aniline
(5e)-n-[(4-hydroxy-3-methoxyphenyl)methyl]-7-methyloct-5-enimidic acid
C17H25NO3 (291.18343400000003)
(1r,15r)-16-isopropyl-15-methyl-3,14-dioxa-11-azapentacyclo[7.5.1.1²,⁵.0¹,¹¹.0⁶,¹⁵]hexadecan-4-one
C17H25NO3 (291.18343400000003)
5-(2-hydroxy-2-phenylethyl)-2,4-dimethyl-hexahydrofuro[3,2-b]pyridin-2-ol
C17H25NO3 (291.18343400000003)
1-[6-methyl-7-(oxan-2-yl)hepta-4,6-dienoyl]pyrrolidin-2-one
C17H25NO3 (291.18343400000003)
(6s,6ar,8r,10s,10as)-2-methoxy-6,6a,8,10-tetramethyl-6h,7h,8h,9h,10h,10ah-isochromeno[4,3-c]pyridin-1-one
C17H25NO3 (291.18343400000003)
[1-(carboxylatomethyl)-2-(non-8-en-1-yl)pyridin-4-ylidene](methyl)oxidanium
C17H25NO3 (291.18343400000003)
(1r,4s,5s,6s,9s)-5-hydroxy-6-methyl-13-azatetracyclo[11.3.1.0¹,⁹.0⁴,⁹]heptadecane-2,8-dione
C17H25NO3 (291.18343400000003)
2-heptyl-2-hydroxy-6-methoxy-4-methyl-1h-indol-3-one
C17H25NO3 (291.18343400000003)
methyl 3-{8-hydroxy-1-azatricyclo[7.3.1.0⁵,¹³]trideca-3,5-dien-13-yl}-2-methylpropanoate
C17H25NO3 (291.18343400000003)
methyl (1s,7s,8r,10s,12s)-8-hydroxy-14-methyl-3-azatetracyclo[9.3.1.0³,¹².0⁷,¹²]pentadec-11(15)-ene-10-carboxylate
C17H25NO3 (291.18343400000003)
9-[1-(4-methyl-5-oxo-2h-furan-2-yl)propyl]-octahydropyrrolo[1,2-a]azepin-3-one
C17H25NO3 (291.18343400000003)
10-ethyl-14-methyl-12-oxa-4-azatetracyclo[7.6.1.0⁴,¹⁶.0¹¹,¹⁵]hexadecane-3,13-dione
C17H25NO3 (291.18343400000003)
(1r,2r,5s,6s,9s,15r,16s)-16-isopropyl-15-methyl-3,14-dioxa-11-azapentacyclo[7.5.1.1²,⁵.0¹,¹¹.0⁶,¹⁵]hexadecan-4-one
C17H25NO3 (291.18343400000003)
(2s,3as,5s,7as)-5-[(2s)-2-hydroxy-2-phenylethyl]-2,4-dimethyl-hexahydrofuro[3,2-b]pyridin-2-ol
C17H25NO3 (291.18343400000003)
(2r,3ar,5r,7ar)-5-[(2r)-2-hydroxy-2-phenylethyl]-2,4-dimethyl-hexahydrofuro[3,2-b]pyridin-2-ol
C17H25NO3 (291.18343400000003)
n-[(4-hydroxy-3-methoxyphenyl)methyl]-7-methyloct-5-enimidic acid
C17H25NO3 (291.18343400000003)
(1ar,5s,6s,7s,7ar,7bs)-5-[(1e,3e)-4-cyclopropyl-2-methylbuta-1,3-dien-1-yl]-7-methyl-hexahydro-1ah-oxireno[2,3-g]indolizine-6,7-diol
C17H25NO3 (291.18343400000003)
methyl 2-[6-(2-hydroxy-2-phenylethyl)-1-methylpiperidin-2-yl]acetate
C17H25NO3 (291.18343400000003)
2-methoxy-6,6a,8,10-tetramethyl-6h,7h,8h,9h,10h,10ah-isochromeno[4,3-c]pyridin-1-one
C17H25NO3 (291.18343400000003)
(6s,6ar,8r,10s,10ar)-2-methoxy-6,6a,8,10-tetramethyl-6h,7h,8h,9h,10h,10ah-isochromeno[4,3-c]pyridin-1-one
C17H25NO3 (291.18343400000003)
methyl (1s,7s,8r,10s,12s,14s)-8-hydroxy-14-methyl-3-azatetracyclo[9.3.1.0³,¹².0⁷,¹²]pentadec-11(15)-ene-10-carboxylate
C17H25NO3 (291.18343400000003)
n,n-dimethyl-2-[(3r)-1h,2h,3h,9h-pyrrolo[2,1-b]quinazolin-3-yl]aniline
(1r,9r,10r,11s,14s,15s,16r)-10-ethyl-14-methyl-12-oxa-4-azatetracyclo[7.6.1.0⁴,¹⁶.0¹¹,¹⁵]hexadecane-3,13-dione
C17H25NO3 (291.18343400000003)